Rheumato id a rth ritis (R A) is a ch ronic auto immune diso rder cha racterized by infla mma tio n a nd joint destructio n. Various genetic studies have identified 100 susceptible genes linked with RA. Amo ng them, four SNPs (rs6671847, rs1801274, rs17400517, and rs6668534) in the FCGR2A gene have been shown to be associated w ith R A susceptibil ity. The functio nal consequences of these pathogenic va riants on the pro tein structure, stability, and interactio n with other molecules remain unk nown. In this study, we used mul tiple in sil ico methods to exa mine the effects of these muta tio ns o n the FCGR2 A gene. We annota ted the gene structurally, and functionally, and Predicted physiochemical cha racterization, gene ex pressio n profiling, and Po st-translatio nal mo dif icatio n (PTM) analysis. We found that the (rs1801274 H167R) mutation in FCGR2 A ha d a significa nt effect on the protein structure and interactio ns, whereas the other th ree SNPs (rs6671847, rs17400517, and rs666853 4) had no significant impact on protein function. We also performed protein-pro tein interaction and molecular docking studies to identify potential thera peutic ta rgets for R A. Our structure -based analysis showed that these mutations affect the protein coreregions and functional domains, leading to altered pro tein -protein interactions both directly and indirectly. We identif ied three novel potential ta rgetsites for the development of drugs to treat R A by developing a drugability profile. These findings may have significant implications for the pathogenesis of R A and can be validated further through in vitro studies. Our study demonstra tes the potential utility of multidirectional computational a nalysis for screening clinically relevant mutations in RA before undertaking biological assays. The findings highlight the importance of understanding the structural and functional consequences of pathogenic variants for developing effective therapeutic strategies. Overall, the insights gained from our in -silico approaches co uld aid in the development of novel therapies for R A and could pave the way for modified medicine in the treatment of this complex disease.